BasemSaidGoueliMDPhD, MBA

Oncology • Williamsville, NY

Associate Chief of Hematology/Medical Oncology for the University of Buffalo and Director of Hematology/Medical Oncology for Great Lakes Cancer Care

Join to view full profile

Dr. Goueli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goueli's full profile

Already have an account?

Office
45 Spindrift Dr
Williamsville, NY 14221
Phone+1 716-422-5422

Fax+1 716-692-4342

Education & Training

Stanford Health CarePost-Doctoral Fellowship, 2011 - 2012
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2008 - 2011
George Washington UniversityResidency, Internal Medicine, 2005 - 2008
Mayo Clinic College of MedicineClass of 2005
Mayo ClinicBiochemistry, 2003
University of MinnesotaBiochemistry, 1992 - 1996
University of MinnesotaScience Genetics/Cell Biology, 1992 - 1996

Certifications & Licensure

MO State Medical License 2019 - 2026
NY State Medical License 2019 - 2026
CA State Medical License 2008 - 2025
TN State Medical License 2018 - 2025
MN State Medical License 2012 - 2024
DC State Medical License 2005 - 2008
VA State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Named as the top oncologist in Duluth Lake Superior Magazine, 2013
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
Completed
Phase 1, Phase 2
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Start of enrollment: 2015 Feb 11
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

412 citations
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea, Angela G. Fleischman, Anupriya Agarwal
The New England Journal of Medicine. 2013-05-08
32 citations
TBC1D16 is a Rab4A GTPase activating protein that regulates receptor recycling and EGF receptor signaling
Basem S. Goueli, Marianne Broome Powell, Elizabeth C. Finger, Suzanne R. Pfeffer
Proceedings of the National Academy of Sciences of the United States of America. 2012-09-25
104 citations
Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
Basem S. Goueli, Ralf Janknecht
Molecular and Cellular Biology. 2004-01-01

Journal Articles

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
N Engl J Med, 1/1/2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Racko..., N Engl J Med, 1/1/2018
TBC1D16 is a Rab4A GTPase activating protein that regulates receptor recycling and EGF receptor signaling
Goueli BS, Powell M, Finger EC, and Pfeffer SR, Proc Natl Acad Sci USA, 1/1/2012
Upregulation of the Catalytic Telomerase Subunit by the transcription factor ER81 and Oncogenic HER2/Neu, Ras, or Raf
Goueli BS and Janknecht R, Mol Cell Biol, 1/1/2004
Her2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1
Bosc DG, Goueli BS, and Janknecht R, Oncogene, 1/1/2001
A novel and simple method to assay the activity of individual protein kinases in a crude tissue extract
Goueli BS, Hsiao K, and Goueli SA, Methods Mol Med, 1/1/2001
A novel and simple method to assay the activity of individual protein kinases in a crude tissue extract
Goueli BS, Hsiao K, Tereba A, and Goueli SA, Anal Biochem, 1/1/1995
Join now to see all

Lectures

Generation of Reactive Oxygen Species and Reactive Nitrogen Oxygen Species
1/1/2016
Antioxidants
1/1/2016
Plasma Composition and Red Blood Cell Metabolism
1/1/2016
Iron Metabolism
1/1/2016
Heme Metabolism
1/1/2016
The Biochemistry of Hemostasis
1/1/2016
Join now to see all

Other

Doctors on Call
Goueli BS
https://www.wdse.org/shows/doctors/watch/cancer-2
1/1/2015
Optimizing one�s chances at surviving cancer
Goueli BS
https://www.youtube.com/watch?v=6Nnb6JhsSXQ&t=37s